Fluoxetine for bulimia nervosa following poor response to psychotherapy. 2000

B T Walsh, and W S Agras, and M J Devlin, and C G Fairburn, and G T Wilson, and C Kahn, and M K Chally
Department of Psychiatry, College of Physicians and Surgeons, Columbia University, and the New York State Psychiatric Institute, New York, NY 10032, USA. btw1@columbia.edu

OBJECTIVE This was an investigation of whether treatment with fluoxetine is useful for individuals with bulimia nervosa who do not respond to psychotherapy or relapse afterward. METHODS Twenty-two patients with bulimia nervosa who had not responded to, or had relapsed following, a course of cognitive behavior therapy or interpersonal psychotherapy were randomly assigned to receive placebo (N=9) or fluoxetine (60 mg/day, N=13) for 8 weeks. RESULTS The median frequency of binge eating in the previous 28 days declined from 22 to four episodes in the fluoxetine group but increased from 15 to 18 episodes in the placebo group. Similarly, purging frequency in the previous 28 days declined from 30 to six episodes in the fluoxetine group but increased from 15 to 38 episodes in the placebo group. CONCLUSIONS Fluoxetine may be a useful intervention for patients with bulimia nervosa who have not responded adequately to psychological treatment.

UI MeSH Term Description Entries
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011613 Psychotherapy A generic term for the treatment of mental illness or emotional disturbances primarily by verbal or nonverbal communication. Psychotherapies
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002032 Bulimia Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as "ox hunger". Binge Eating,Bulimias,Eating, Binge
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015928 Cognitive Behavioral Therapy A directive form of psychotherapy based on the interpretation of situations (cognitive structure of experiences) that determine how an individual feels and behaves. It is based on the premise that cognition, the process of acquiring knowledge and forming beliefs, is a primary determinant of mood and behavior. The therapy uses behavioral and verbal techniques to identify and correct negative thinking that is at the root of the aberrant behavior. Behavior Therapy, Cognitive,Cognitive Behaviour Therapy,Cognitive Therapy,Psychotherapy, Cognitive,Cognition Therapy,Cognitive Behavior Therapy,Cognitive Psychotherapy,Therapy, Cognition,Therapy, Cognitive,Therapy, Cognitive Behavior,Behavior Therapies, Cognitive,Behavioral Therapies, Cognitive,Behavioral Therapy, Cognitive,Behaviour Therapies, Cognitive,Behaviour Therapy, Cognitive,Cognition Therapies,Cognitive Behavior Therapies,Cognitive Behavioral Therapies,Cognitive Behaviour Therapies,Cognitive Psychotherapies,Cognitive Therapies,Psychotherapies, Cognitive,Therapies, Cognition,Therapies, Cognitive,Therapies, Cognitive Behavior,Therapies, Cognitive Behavioral,Therapies, Cognitive Behaviour,Therapy, Cognitive Behavioral,Therapy, Cognitive Behaviour

Related Publications

B T Walsh, and W S Agras, and M J Devlin, and C G Fairburn, and G T Wilson, and C Kahn, and M K Chally
May 1995, The British journal of psychiatry : the journal of mental science,
B T Walsh, and W S Agras, and M J Devlin, and C G Fairburn, and G T Wilson, and C Kahn, and M K Chally
December 2006, Prescrire international,
B T Walsh, and W S Agras, and M J Devlin, and C G Fairburn, and G T Wilson, and C Kahn, and M K Chally
January 1991, Journal of psychosomatic research,
B T Walsh, and W S Agras, and M J Devlin, and C G Fairburn, and G T Wilson, and C Kahn, and M K Chally
May 1993, The International journal of eating disorders,
B T Walsh, and W S Agras, and M J Devlin, and C G Fairburn, and G T Wilson, and C Kahn, and M K Chally
January 1987, International journal of obesity,
B T Walsh, and W S Agras, and M J Devlin, and C G Fairburn, and G T Wilson, and C Kahn, and M K Chally
January 2004, The Cochrane database of systematic reviews,
B T Walsh, and W S Agras, and M J Devlin, and C G Fairburn, and G T Wilson, and C Kahn, and M K Chally
January 2001, The Cochrane database of systematic reviews,
B T Walsh, and W S Agras, and M J Devlin, and C G Fairburn, and G T Wilson, and C Kahn, and M K Chally
January 2000, The Cochrane database of systematic reviews,
B T Walsh, and W S Agras, and M J Devlin, and C G Fairburn, and G T Wilson, and C Kahn, and M K Chally
January 2000, The Cochrane database of systematic reviews,
B T Walsh, and W S Agras, and M J Devlin, and C G Fairburn, and G T Wilson, and C Kahn, and M K Chally
January 2003, The Cochrane database of systematic reviews,
Copied contents to your clipboard!